Anemia
📧 Sign up to get email alerts when something new happens for Anemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-06-06Clinical Trial Update: Establishment of Optimal Transfusion Threshold After Major Orthopedic Surgery [NA]
The trial evaluating the optimal transfusion threshold after major orthopedic surgery has completed. It is sponsored by Rigshospitalet, Denm…
-
CLINICAL_TRIALS trial_result · 2011-05-26Clinical Trial Update: Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer [NA]
This document reports a terminated clinical trial evaluating epoetin alfa for chemotherapy-related anemia in cancer patients, with results p…
-
CLINICAL_TRIALS trial_result · 2011-05-25Clinical Trial Update: Safety of Capsule Endoscopy in Patients With Implantable Cardiac Devices
This completed clinical trial assessed the safety of capsule endoscopy in patients with implantable cardiac devices and reported on its safe…
-
CLINICAL_TRIALS trial_result · 2011-05-23Clinical Trial Update: A Study of Four Dosing Regimens of PROCRIT (Epoetin Alfa) in Patients With Chronic Kidney Disease. Protocol Addendum: Extension Study of Maintenance Therapy of PROCRIT (Epoetin Alfa) in Patients With Chronic Kidney Disease. [Phase 2]
Phase 2 clinical trial update examining four dosing regimens of PROCRIT (epoetin alfa) in patients with chronic kidney disease and anemia, p…
-
CLINICAL_TRIALS trial_result · 2011-05-23Clinical Trial Update: Alternate Dosing - Initiation of Every 2 Week Epoetin Alfa (PROCRIT) in the Treatment of Anemia. [Phase 2]
Phase 2 trial update examining alternate dosing by initiating every two weeks of epoetin alfa (Procrit) to treat anemia associated with kidn…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-05-23Clinical Trial Update: A Study to Evaluate the Effect of Weekly PROCRIT (Epoetin Alfa) or Placebo on Anemia and Quality of Life in Children With Cancer Undergoing Chemotherapy [Phase 3]
A Phase 3 study evaluating weekly epoetin alfa (PROCRIT) versus placebo for anemia and quality of life in children receiving chemotherapy fo…
-
CLINICAL_TRIALS trial_result · 2011-05-19Clinical Trial Update: A Study to Evaluate PROCRIT (Epoetin Alfa) for Maintenance Phase Treatment of Patients With Anemia Due to Chronic Kidney Disease (PROMPT) [Phase 2]
This Phase 2 clinical trial update reports on maintenance therapy with PROCRIT (epoetin alfa) for anemia associated with chronic kidney dise…
-
CLINICAL_TRIALS trial_result · 2011-05-19Clinical Trial Update: A Phase III Clinical Trial of PROCRIT (Epoetin Alfa) Versus Placebo in Women Undergoing Adjuvant Chemotherapy for Stage I, II or III Breast Cancer [Phase 3]
A Phase III trial evaluating PROCRIT (epoetin alfa) versus placebo in women undergoing adjuvant chemotherapy for breast cancer was terminate…
-
CLINICAL_TRIALS trial_result · 2011-05-19Clinical Trial Update: A Study of the Safety and Effectiveness of Epoetin Alfa on Hemoglobin Levels and Blood Transfusions in Cancer Patients Receiving Chemotherapy [Phase 4]
Phase 4 study assessing the safety and effectiveness of epoetin alfa on hemoglobin levels and transfusion requirements in cancer patients un…
-
CLINICAL_TRIALS trial_result · 2011-05-19Clinical Trial Update: An Open-Label Study to Evaluate the Effect of Every Other Week PROCRIT� (Epoetin Alfa) Dosing (40,000-60,000 Units) On Maintaining Quality of Life and Target Hemoglobin Levels in Anemic HIV-Infected Patients (CHAMPS II) [Phase 4]
Phase 4 open-label study evaluating every-other-week dosing of epoetin alfa (PROCRIT) to maintain quality of life and target hemoglobin in a…
-
CLINICAL_TRIALS trial_result · 2011-05-19Clinical Trial Update: A Study to Assess the Response Rate of PROCRIT (Epoetin Alfa) Given at a Dose of 40,000 Units Once a Week to Cancer Patients With Anemia Who Are Not Receiving Chemotherapy. [Phase 3]
A Phase 3 study evaluating weekly 40,000 units of epoetin alfa (PROCRIT) in cancer patients with anemia who are not receiving chemotherapy w…
-
CLINICAL_TRIALS trial_result · 2011-05-19Clinical Trial Update: NATURAL HISTORY-Hepatitis C Virus/ Human Immunodeficiency Virus Coinfection [Phase 2]
Phase 2 clinical trial investigating coinfection of Hepatitis C and HIV has completed. Anemia is listed among the study conditions.
-
CLINICAL_TRIALS trial_result · 2011-05-19Clinical Trial Update: A Study to Assess Disability in Anemic Elderly Patients With Kidney Disease Receiving PROCRIT (Epoetin Alfa) [Phase 4]
A Phase 4 trial assessing disability in anemic elderly patients with kidney disease treated with Procrit (epoetin alfa) has been terminated.
-
CLINICAL_TRIALS trial_result · 2011-05-19Clinical Trial Update: A Study to Evaluate the Erythropoietic Response in Hepatitis C Virus (HCV) Patients Receiving Combination Ribavirin (RBV)/Interferon (IFN) Therapy or RBV/PEG IFN (NATURAL HISTORY-HCV) [Phase 2]
Phase 2 study evaluating erythropoietic response in hepatitis C patients treated with ribavirin plus interferon or ribavirin plus pegylated …
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: A Study to Determine the Safety of Epoetin Alfa and Whether Epoetin Alfa Can Reduce the Need for Blood Transfusions in Patients After Major Orthopedic Surgery. [Phase 2]
Phase 2 study evaluating the safety of epoetin alfa and whether it can reduce the need for blood transfusions after major orthopedic surgery…
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa in Patients With Anemia as a Result of Advanced Cancer and Treatment With Aggressive Chemotherapy [Phase 2]
Phase 2 study evaluating the safety and effectiveness of epoetin alfa for treating anemia in patients with advanced cancer undergoing aggres…
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: PROCRIT (Epoetin Alfa) 60,000 Units Administered Once Every Two Weeks in Anemic Cancer Patients Who Are Not Receiving Chemotherapy or Radiation Therapy [Phase 2]
Phase 2 trial evaluating epoetin alfa (PROCRIT) 60,000 units given every two weeks in anemic cancer patients not receiving chemotherapy or r…
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: A Study to Evaluate the Safety of Epoetin Alfa and Its Effectiveness in Facilitating the Presurgical Collection of Blood From Anemic Patients for Possible Self-transfusion During and After Scheduled Joint Surgery. [Phase 3]
Phase 3 study evaluating the safety and effectiveness of epoetin alfa to enable presurgical autologous blood collection in anemic patients u…
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: Correction of Hemoglobin and Outcomes in Renal Insufficiency (CHOIR) [Phase 4]
The Phase 4 CHOIR trial evaluating correction of hemoglobin in anemia due to renal insufficiency was terminated. This update provides the tr…
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: A Study of the Safety and Effectiveness of Epoetin Alfa in Facilitating Self-donation of Blood Before Surgery in Patients Who Are Undergoing Orthopedic Surgery and Who Have Low Hematocrit Levels (the Percent of Red Blood Cells in Whole Blood) [Phase 2, Phase 3]
A completed Phase 2/3 trial evaluating epoetin alfa to facilitate self-donation of blood before orthopedic surgery in patients with low hema…
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa in AIDS Patients With Anemia Caused Both by Their Disease and by AZT (Zidovudine, an Antiviral Drug) Given as Treatment for Their Disease [Phase 2]
This Phase 2 trial evaluated the safety and effectiveness of epoetin alfa in patients with Acquired Immunodeficiency Syndrome who had anemia…
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo for the Treatment of Anemia in Patients With Acquired Immunodeficiency Syndrome (AIDS) Who Are Receiving Zidovudine (AZT) Therapy [Phase 2]
Phase 2 study comparing epoetin alfa to placebo for treating anemia in AIDS patients on zidovudine has completed, assessing safety and effic…
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa in AIDS (Acquired Immunodeficiency Syndrome) Patients With Anemia Caused Both by Their Disease and by AZT (Zidovudine, an Antiviral Drug) Given as Treatment for Their Disease [Phase 2]
Phase 2 study evaluating the safety and effectiveness of epoetin alfa in AIDS patients with anemia (caused by both HIV/AIDS and AZT treatmen…
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo for the Treatment of Anemia in AIDS (Acquired Immunodeficiency Syndrome) Patients With Anemia Caused by the Disease and by Zidovudine (AZT) Therapy [Phase 2]
Phase 2 trial comparing epoetin alfa to placebo for anemia in AIDS patients with anemia caused by the disease or AZT therapy; study complete…
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa Versus Placebo in Patients With Persistent Anemia as a Result of Cancer Treatment With Cisplatin, a Platinum-containing Chemotherapy Drug [Phase 2]
A Phase 2 trial comparing epoetin alfa to placebo for persistent anemia resulting from cisplatin-based cancer therapy, assessing safety and …